Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$1.17 - $2.7 $1,324 - $3,056
1,132 Added 9.25%
13,369 $24,000
Q4 2022

Feb 13, 2023

BUY
$2.38 - $3.55 $7,285 - $10,866
3,061 Added 33.36%
12,237 $32,000
Q3 2022

Nov 07, 2022

BUY
$3.14 - $4.87 $9,014 - $13,981
2,871 Added 45.54%
9,176 $30,000
Q2 2022

Aug 09, 2022

BUY
$3.03 - $5.32 $19,104 - $33,542
6,305 New
6,305 $22,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $234M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.